Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Pacira Pharmaceuticals, Inc. (PCRX)    
$29.30 0.43 (1.45%) as of 4:30 Fri 5/24


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 32,553,000 as of 6/30
Market Cap: 953.80(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $10.16 - $30.08
Level I Sector: Health Care
Level II Sector:   Drugs
Level III Sector:      Drug Manufacturers - Major

Member Indexes:
      

Rankings:
     
Insider 3 Months    : 4.9
Insider 6 Months    : 4.9
Insider 3/6 Months : 10.1
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
 

Company Profile   Pacira Pharmaceuticals is a holding company. Through its subsidiaries, Co. is a pharmaceutical company focused on the development, commercialization and manufacture of pharmaceutical products, based on its DepoFoam drug delivery technology, for use in hospitals and ambulatory surgery centers. Co.'s main product candidate is EXPAREL, a bupivacaine (anesthetic/analgesic) product for postsurgical pain management. Co.'s marketed products and their respective indication are DepoCyt(e) for lymphomatous meningitis; and DepoDur for post-operative pain; while its preclinical products and their respective indication are DepoNSAID for acute pain and DepoMethotrexate for rheumatoid arthritis oncology.
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 853 853 853 3,635,685
Total Buy Value $24,993 $24,993 $24,993 $24,487,472
Total People Bought 1 1 1 9
Total Buy Transactions 1 1 1 12
Total Shares Sold 5,926,882 6,926,882 6,926,882 7,309,823
Total Sell Value $160,739,609 $179,669,609 $179,669,609 $183,835,550
Total People Sold 13 13 13 14
Total Sell Transactions 44 46 46 55
End Date 2013-02-24 2012-11-23 2012-05-25 2011-05-26

   
Records found: 52
  Page 1 of 3  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Isaly Samuel D 10% Owner   –       –       •   2012-02-29 4 S $10.86 $32,584 I/I (3,000) 2,546,100 -44%     
   Isaly Samuel D 10% Owner   –       –       •   2012-02-28 4 S $11.12 $112,316 I/I (10,100) 2,549,100 -45%     
   Isaly Samuel D 10% Owner   –       –       •   2012-02-27 4 S $11.05 $320,369 I/I (29,000) 2,559,200 -45%     
   Greene William 10% Owner   –       –       •   2012-02-08 4 A $0.00 $0 I/I 2,200,247 2,293,227     -
   Evnin Luke Director   –       •       •   2012-02-08 4 B $7.00 $3,749,998 I/I 535,714 2,828,941 2.25 44%     
   Evnin Luke Director   –       •       •   2012-02-08 4 A $0.00 $0 I/I 2,200,247 2,293,227     -
   Greene William 10% Owner   –       –       •   2012-02-08 4 B $7.00 $3,749,998 I/I 535,714 2,828,941 1.5 44%     
   Gadicke Ansbert 10% Owner   –       –       •   2012-02-08 4 B $7.00 $3,749,998 I/I 535,714 2,828,941 1.5 44%     
   Gadicke Ansbert 10% Owner   –       –       •   2012-02-08 4 A $0.00 $0 I/I 2,200,247 2,293,227     -
   Isaly Samuel D 10% Owner   –       –       •   2012-02-03 4 S $10.79 $539,520 I/I (50,000) 2,588,200 -30%     
   Isaly Samuel D 10% Owner   –       –       •   2012-02-02 4 S $10.85 $252,917 I/I (23,300) 2,638,200 -26%     
   Isaly Samuel D 10% Owner   –       –       •   2012-02-01 4 S $11.01 $770,406 I/I (70,000) 2,661,500 -25%     
   Middleton Fred A Director   –       •       •   2011-11-21 4 B $6.50 $65,000 D/D 10,000 10,000 3.92 50%     
   Evnin Luke Director   –       •       •   2011-11-21 4 B $6.50 $2,999,997 I/I 461,538 3,290,479 2.25 50%     
   Wicki Andreas Director   –       •      –    2011-11-21 4 B $6.50 $1,999,998 I/I 307,692 3,445,289 2.1 50%     
   Gadicke Ansbert 10% Owner   –       –       •   2011-11-21 4 B $6.50 $2,999,997 I/I 461,538 3,290,479 1.5 50%     
   St Peter Steven 10% Owner   –       –       •   2011-11-21 4 B $6.50 $2,999,997 I/I 461,538 3,290,479 1.5 50%     
   Hbm Bioventures Cayman Ltd 10% Owner   –       –       •   2011-11-21 4 B $6.50 $1,999,998 D/D 307,692 3,445,289 2.45 50%     
   Pace Gary W Director   –       •      –    2011-11-21 4 B $6.50 $49,998 D/D 7,692 7,692 2.39 50%     
   Isaly Samuel D 10% Owner   –       –       •   2011-10-31 4 S $10.53 $1,025,635 I/I (97,441) 2,731,500 -15%     
   Stack David M President and CEO   •       •      –    2011-08-10 5 GD $0.00 $0 D/D 3,000 20,600     -
   Scibetta James S Chief Financial Officer   •       –      –    2011-02-15 4 B $7.04 $35,200 D/D 5,000 5,000 2.74 74%     
   Stack David M President and CEO   •       •      –    2011-02-10 4 B $6.60 $33,000 D/D 5,000 23,600 2.81 87%     
   Gadicke Ansbert 10% Owner   –       –       •   2011-02-08 4/A A $0.00 $0 I/I 2,200,247 2,293,227     -
   Gadicke Ansbert 10% Owner   –       –       •   2011-02-08 4/A B $7.00 $3,749,998 I/I 535,714 2,828,941 1.5     -
  52 Records found
  1  2  3   
  Page 1 of 3
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2010 J3SG.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us